Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberculosis--immunopathogenesis and therapy

J C Weissler1

  • 1Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas 75235-9034.

The American Journal of the Medical Sciences
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BR22, a 26 kDa thyroid transcription factor-1 associated protein (TAP26), is expressed in human lung cells.

The European respiratory journal·2003
Same author

Autoantigen Ro52 directly interacts with human IgG heavy chain in vivo in mammalian cells.

Molecular immunology·2001
Same author

BR22, a novel protein, interacts with thyroid transcription factor-1 and activates the human surfactant protein B promoter.

American journal of respiratory cell and molecular biology·2001
Same author

Syndromes of severe asthma.

The American journal of the medical sciences·2000
Same author

The hospitalist movement: caution lights flashing at the crossroads.

The American journal of medicine·1999
Same author

Increased bronchoalveolar IgG2/IgG1 ratio is a marker for human lung allograft rejection.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·1994

Mycobacterium tuberculosis (tuberculosis) infection is a growing public health concern. This review covers host responses, epidemiology, and optimal treatment strategies for TB.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Epidemiology

Background:

  • Tuberculosis (TB) infection is experiencing a resurgence, increasing public and medical concern.
  • Significant advancements in understanding TB pathogenesis are emerging.
  • Basic research findings are increasingly being translated into clinical applications.

Purpose of the Study:

  • To review current concepts of host response to Mycobacterium tuberculosis.
  • To discuss the evolving epidemiology of tuberculosis.
  • To outline optimal treatment strategies for TB.

Main Methods:

  • Literature review of recent research on TB.
  • Synthesis of current knowledge on host-pathogen interactions.
  • Analysis of epidemiological trends and treatment outcomes.

Related Experiment Videos

Main Results:

  • Detailed examination of the host immune response to TB infection.
  • Updated epidemiological data highlighting the increasing incidence of TB.
  • Evaluation of current and emerging therapeutic approaches for TB.

Conclusions:

  • Understanding host responses is crucial for combating TB.
  • Addressing changing TB epidemiology requires adaptive strategies.
  • Optimizing treatment is essential for controlling the global TB burden.